VR
NASDAQ · VRAX
Virax Biolabs Group Limited
Healthcare · Biotechnology
$0.79
Down-$0.39 (-32.89%)
Updated Nov 9, 2026, 3:16 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.92M
- P/E ratio
- -0.37
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $13.19
- Volume
- 1.1M
- Avg. volume
- 5.08M
Price performance · VRAX
VRAX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
VRAX closed at $0.79 after 20 trading sessions, down 57.19% for the selected period.
- Last close
- $0.79
- Period change
- -57.19%
- Period low
- $0.79
- Period high
- $1.85
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $0.97 | $0.9899 | $0.63 | $0.7919 | 1.1M |
| Nov 5, 2026 | $1.33 | $1.3492 | $1.01 | $1.18 | 3.71M |
| Nov 4, 2026 | $1.16 | $1.57 | $1.11 | $1.20 | 10.98M |
| Nov 3, 2026 | $1.09 | $1.175 | $1.04 | $1.06 | 33.72K |
| Nov 2, 2026 | $1.17 | $1.18 | $1.10 | $1.10 | 25.61K |
| Oct 30, 2026 | $1.285 | $1.30 | $1.18 | $1.21 | 23.67K |
| Oct 29, 2026 | $1.30 | $1.33 | $1.235 | $1.32 | 58.27K |
| Oct 28, 2026 | $1.17 | $1.21 | $1.16 | $1.20 | 10.07K |
| Oct 27, 2026 | $1.23 | $1.23 | $1.14 | $1.19 | 11.93K |
| Oct 26, 2026 | $1.26 | $1.26 | $1.18 | $1.19 | 10.47K |
| Oct 23, 2026 | $1.24 | $1.2651 | $1.20 | $1.22 | 33.98K |
| Oct 22, 2026 | $1.29 | $1.39 | $1.15 | $1.235 | 38.26K |
| Oct 21, 2026 | $1.42 | $1.49 | $1.32 | $1.34 | 14.71K |
| Oct 20, 2026 | $1.50 | $1.50 | $1.35 | $1.37 | 14.06K |
| Oct 19, 2026 | $1.50 | $1.6478 | $1.38 | $1.40 | 12.09K |
| Oct 16, 2026 | $1.62 | $1.64 | $1.38 | $1.45 | 40.63K |
| Oct 15, 2026 | $1.66 | $1.76 | $1.55 | $1.6202 | 44.19K |
| Oct 14, 2026 | $1.77 | $1.78 | $1.61 | $1.65 | 38.75K |
| Oct 13, 2026 | $1.80 | $1.86 | $1.7201 | $1.7381 | 43.75K |
| Oct 12, 2026 | $1.81 | $1.8999 | $1.78 | $1.85 | 71.26K |
Latest VRAX news
The latest Smart Investors Daily articles mentioning VRAX.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…
